We are monitoring the impact of COVID-19 on Europe CTMS Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 10637
Share on
Share on

Europe Clinical Trial Management System Market Research Report – Segmented By Delivery Mode, Component, Type of System, End User & Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands & Rest of Europe) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 10637
Pages: 120

Europe CTMS Market Size (2021 to 2026)

The size of the European CTMS market was valued at USD 331.17 Million in 2021 and expected to reach USD 701.59 Million by 2026, to grow at a CAGR of 16.20% between 2021 to 2026.

Factors such as increasing outsourcing of clinical trials, Y-o-Y growth in the incidence of chronic diseases, and growing R&D activities are majorly driving the CTMS market growth in this region. It is further accelerated by the European government's increasing investments towards healthcare, and easy accessibility of CTMS technologies is driving the market growth.

Furthermore, the rising number of healthcare service providers, erupting several healthcare end-users, which will boost further CTMS market. An increase in the obtainment of CTMS over the last few years has boosted market growth over the review period. Moreover, growing awareness and the requirement for the extra cost to be cut down are estimated to drive the market growth over the analysis period.

The high costs associated with the CTMS is estimated to hamper market growth slightly. The shortage of skilled professionals, particularly in developing countries, is aspiring the pharmaceutical and biotechnology firms are restraining the market growth. Stringent rules in different countries may lead to hard clinical trial protocols, which will restrain the growth of CTMS over the period. Moreover, the treatment process is a very lengthy procedure that may hamper growth. Having less awareness among the researchers regarding the benefits of the CTMS is impeding the market growth. Increasing clinical trial failures is obstructing the market. Strict and lengthy approvals for the products and therapeutics also restrict the growth over the period.

This research report segmented and sub-segmented the Europe clinical trial management system market into the following categories:

By Delivery Mode:

  • Web-based CTMS
  • On-premise CTMS
  • Cloud-based CTMS

By Component:

  • Software
  • Hardware
  • Services

By End User:

  • Pharmaceuticals
  • Clinical Research Organization
  • Other End Users

By Type of System:

  • Site-based Licensed Enterprise-based
  • Licensed Enterprise-based

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

Regional Analysis:

The European clinical trial management system market is anticipated to show promising growth and rise at a robust CAGR during the forecast period due to the increasing IT healthcare industry and the high authenticity of the level of information provided by CTMS.

The German CTMS market is anticipated to have the highest share of the region throughout the forecast period. The growth is projected due to a growing aging population within a short period of time, an increasing number of clinical trials, and a growing acquisition of CTMS. 

The UK CTMS Market is the second-largest country of this region, followed by Germany, and the growth is owed to advanced technologies. Growing demand for new therapies is driving the UK market in CTMS. According to UK Research and Innovation, the number of processes carried out in medical research in 2018 was nearly 268,032. 

Some of the prominent companies dominating the European CTMS market profiled in this report are Bioclinica, Bio-Optronics Inc., DATATRAK International Inc., ERT Clinical, IBM, Medidata Solutions Inc., MedNet Solutions, Inc., Oracle, Parexel International Corporation, and ArisGlobal.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Delivery Mode
      1. Web-based CTMS
      2. On-premise CTMS
      3. Cloud-based CTMS
      4. Y-o-Y Growth Analysis, By Delivery Mode
      5. Market Attractiveness Analysis, By Delivery Mode
      6. Market Share Analysis, By Delivery Mode
    2. By Component
      1. Software
      2. Hardware
      3. Services
      4. Y-o-Y Growth Analysis, By Component
      5. Market Attractiveness Analysis, By Component
      6. Market Share Analysis, By Component
    3. By End User
      1. Pharmaceuticals
      2. Clinical Research Organization
      3. Other End Users
      4. Y-o-Y Growth Analysis, By End User
      5. Market Attractiveness Analysis, By End User
      6. Market Share Analysis, By End User
    4. By Type of System
      1. Site-based Clinical Trial Management System
      2. Licensed Enterprise-based Clinical Trial Management System
      3. Y-o-Y Growth Analysis, By Type of System
      4. Market Attractiveness Analysis, By Type of System
      5. Market Share Analysis, By Type of System
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Material Type
        3. By Form
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Material Type
        3. By Form
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Material Type
        3. By Form
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Bioclinica
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Bio-Optronics Inc.
    3. DATATRAK International Inc.
    4. ERT Clinical
    5. IBM
    6. Medidata Solutions Inc.
    7. MedNet Solutions Inc.
    8. Oracle
    9. Parexel International Corporation
    10. ArisGlobal
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Request Sample to View LOT & LOF

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample